AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Raptiva.(Drug overview)

PDR Family Guide to Prescription Drugs

| January 22, 2007 | COPYRIGHT 2007 A Thomson Healthcare Company. All rights reserved. Information is intended for End Users' personal use only and may not be sold, redistributed, or otherwise used for commercial purposes. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Pronounced: rap-TEE-vuh

Generic name: Efalizumab

Why is Raptiva prescribed?

Psoriasis is a skin disease that is caused, in part, by an overactive immune system. Raptiva belongs to a class of drugs called immunosuppressives, which decrease the activity of the immune system. It is prescribed for patients with severe plaque psoriasis who can no longer control their disease with medications applied to the skin.

Most important fact about Raptiva

Raptiva, like other immunosuppressive agents, has the potential to increase the risk of serious infections and cancer. Call your doctor immediately if you are diagnosed with cancer or your psoriasis worsens. Also contact your doctor if you develop an infection, excessive bleeding, or unusual bruising.

How should you take Raptiva?

Related articles from newspapers, magazines, journals, and more
Raptiva warnings updated.(Complications and side effects)(Brief Article)
Physician Assistants' Prescribing Reference December 22, 2005 700+ words
The labeling for the immunosuppressive agent, Raptiva (efalizumab, from Genentech) has been updated with a warning regarding events of immune-mediated hemolytic anemia associated...
FDA clears Xoma/Genentech's Raptiva as plaque psoriasis therapy in adults.
Newspaper article from: Pharma Marketletter November 3, 2003 700+ words
...which subjects received Raptiva for 24 weeks (Marketletters passim). Raptiva was well tolerated in...frequently-reported side effects, which occurred in...and myalgia. Serious side effects observed included thrombocytopenia...Marketletters passim). "Raptiva offers a new ...
Serono and Genentech Announce International Marketing Agreement for Psoriasis...
Press release article from: Business Wire August 8, 2002 700+ words
...license to market the psoriasis treatment Raptiva(TM) (efalizumab, formerly Xanelim...developing additional indications for Raptiva and will share certain global development...lasting and may be associated with serious side-effects. There currently is no known cure...
Approval of Xoma/Genentech's Raptiva still on track after backing by FDA panel.
Newspaper article from: Pharma Marketletter September 15, 2003 700+ words
...achieved PASI 50. Good safety profile Raptiva was shown to be well tolerated in...The most frequently-reported side effects, which occurred in at least 5...unanimous recommendation and, if Raptiva is approved, we look forward to...
Genentech/Serono's Raptiva shows long-term benefits in treating plaque...
Newspaper article from: Pharma Marketletter August 9, 2004 700+ words
...study, 339 patients received Raptiva weekly for an initial 12 weeks...of subjects receiving weekly Raptiva. Furthermore, 91% (145...improvement. No new safety issues Side effects reported in the study were...clinical investigations of Raptiva, which include headache...
FDA Advises Public of Serious Adverse Event with Psoriasis Drug Raptiva.
Press release article from: M2 Presswire February 20, 2009 700+ words
...carefully monitor patients on Raptiva, as well as those who have...experience any such symptoms. Raptiva is a once-weekly injection...By suppressing T-cells, Raptiva decreases the function of the...report serious adverse events (side effects) or product quality problems...
Removing Raptiva
Magazine article from: Dermatology Times Jesitus, John June 1, 2009 700+ words
...Genentech was to stop selling Raptiva after June 8. The company...University, New York, says Raptiva's withdrawal is "not a clear...I had 60 or 70 patients on Raptiva, many of them for more than...who experienced significant side effects," some of which began occurring...
MALAYSIAN HEALTH MINISTRY SUSPENDS RAPTIVA.
News wire article from: AsiaPulse News March 4, 2009 700+ words
...Ministry has suspended the product Raptiva immediately because its risks...Eisah A. Rahman, said serious side effects had been reported between September...in patients who had taken Raptiva for more than three years and...psoriasis had been treated with Raptiva which can only be obtained...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA